RMD Open2d
Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use
Objectives The impact of body mass index (BMI) on cardiovascular risk in rheumatoid arthritis (RA) is unclear. RA ...
RMD Open2d
Venous vessel-wall assessment with superb microvascular imaging in Behçet syndrome
Objectives Superb microvascular imaging (SMI) provides a more sensitive assessment of small vessels compared with power and colour Doppler ultrasonography (PDUS and CDUS). We aimed to investigate the ...
RMD Open12d
Correction: experimental myositis: an optimised version of C-protein-induced myositis
Abdelghani M, et al . Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open 2025;11:e004558. doi: 10.1136/rmdopen-2024–0 04 558 In this article, the abstract has been ...
rmdopen.bmj1d
Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
Objective Non-pharmacological interventions support patients with connective tissue diseases to better cope with and self-manage their diseases. This study aimed to map existing evidence on ...
rmdopen.bmj1d
Four trajectories of 24-hour urine protein levels in real-world lupus nephritis cohorts
Objectives A 24-hour urine protein (24hUP) is a key measurement in the management of lupus nephritis (LN); however, trajectories of 24hUP in LN is poorly defined. Methods Two LN cohorts that underwent ...
rmdopen.bmj4d
Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials
Objective To identify patient characteristics associated with responsiveness to tumour necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA). Materials and methods Individual patient data ...
rmdopen.bmj2d
High p16INK4a, a marker of cellular senescence, is associated with renal injury, impairment and outcome in lupus nephritis
Objectives Because a significant fraction of patients with lupus nephritis (LN) develops renal impairment, there is a need to better understand the mechanisms underlying disease progression. Here, we ...
rmdopen.bmj5d
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines
Objective To report the effort of the European Reference Network for Rare and Complex CONnective tissue and musculoskeletal diseases NETwork working group on Ehlers-Danlos syndromes (EDS) and related ...
rmdopen.bmj11d
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (MDA5-DM) is frequently complicated with rapidly progressive-interstitial lung disease (RP-ILD). The ...
rmdopen.bmj8d
Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium
Objectives Programmed cell death protein 1 (PD-1)-expressing T cells are implicated in the pathogenesis of autoimmune inflammatory diseases such as rheumatoid arthritis. A subset of CXCR5 − T cells, ...
rmdopen.bmj5d
Current Issue
Original research: Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use (5 April, 2025) ...